{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:04:54Z","timestamp":1789736694209,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiation syndrome (DS) is a potentially life-threatening complication during induction therapy for acute promyelocytic leukemia (APL). Previous studies have linked white blood cell (WBC) elevation with DS development; however, conventional WBC-based assessment mainly relies on peak values and does not adequately reflect the dynamic pattern or timing of WBC changes. We aimed to develop and internally validate an early warning model for DS based on early WBC kinetics during arsenic trioxide (ATO) induction therapy in patients with low- and intermediate-risk APL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 224 newly diagnosed patients with low- and intermediate-risk APL who received single-agent ATO induction therapy. Early WBC kinetics and baseline clinical parameters were analyzed using least absolute shrinkage and selection operator regression and multivariate logistic regression to construct a nomogram.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DS occurred in 90 patients (40.2%), with a median onset time of 8 days (interquartile range, 7\u201311 days). WBC doubling occurred at a median of 3 days before DS onset, whereas the WBC peak occurred at a median of 2.5 days after DS onset. Rapid WBC proliferation and increased peripheral blood promyelocyte percentage were independent risk factors, whereas prolonged WBC doubling time was associated with reduced DS risk. The nomogram showed good discrimination, with an area under the curve of 0.825 (95% confidence interval, 0.770\u20130.880); the corrected area under the curve remained 0.817 after bootstrap internal validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early WBC kinetic characteristics provide time-sensitive indicators for DS risk assessment. This model may assist with early DS risk stratification and monitoring in low- and intermediate-risk APL patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1961271","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:20:16Z","timestamp":1789734016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic white blood cell kinetics enable early risk stratification of differentiation syndrome in low- and intermediate-risk acute promyelocytic leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiajuan","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]},{"name":"National Health Commission (NHC) Key Laboratory of Cell Transplantation, the First Affiliated Hospital, Harbin Medical University","place":["Harbin, China"]},{"name":"Key Laboratory of Blood and Hematopoietic System in Heilongjiang","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194767","article-title":"Differentiation syndrome in acute leukemia: Apl and beyond","volume":"15","author":"Woods","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199710093371509","article-title":"Differentiation therapy for acute promyelocytic leukemia","volume":"337","author":"Fenaux","year":"1997","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026186","article-title":"Acute promyelocytic leukemia: Long-term outcomes from the Harmony Project","volume":"145","author":"Voso","year":"2025","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-470757","article-title":"Acute promyelocytic leukemia: Progress far and wide","volume":"121","author":"Powell","year":"2013","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s13054-025-05743-7","article-title":"Early mortality in patients with acute promyelocytic leukemia: A systematic review and meta-analysis","volume":"29","author":"Chean","year":"2025","journal-title":"Crit Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004789","article-title":"Characteristics and predictors of early hospital deaths in newly diagnosed Apl: A 13-year population-wide study","volume":"5","author":"Gill","year":"2021","journal-title":"Blood Adv"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107567","article-title":"Distinctive features associated with differentiation syndrome in acute promyelocytic leukemia in patients treated by all-trans retinoic acid and arsenic trioxide","volume":"145","author":"Cingelova","year":"2024","journal-title":"Leuk Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2712","article-title":"Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European Apl Group","volume":"92","author":"De Botton","year":"1998","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16151","article-title":"Differentiation syndrome in acute promyelocytic leukaemia","volume":"187","author":"Stahl","year":"2019","journal-title":"Br J Haematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2000.18.13.2620","article-title":"Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide","volume":"18","author":"Camacho","year":"2000","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08325.x","article-title":"Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia","volume":"151","author":"Luesink","year":"2010","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-204834","article-title":"Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: Triggering the differentiation syndrome","volume":"114","author":"Luesink","year":"2009","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-4-292","article-title":"The \"retinoic acid syndrome\" in acute promyelocytic leukemia","volume":"117","author":"Frankel","year":"1992","journal-title":"Ann Internal Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11935","DOI":"10.1038\/s41598-019-47937-4","article-title":"Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia","volume":"9","author":"Yoon","year":"2019","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/mco.2021.2274","article-title":"Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk","volume":"14","author":"Wen","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.09.006","article-title":"The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia","volume":"61","author":"Wang","year":"2017","journal-title":"Leuk Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2011-07-369595","article-title":"Increased Bmi correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the Aida protocols","volume":"119","author":"Breccia","year":"2012","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"17998","DOI":"10.1038\/s41598-017-18278-x","article-title":"Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06495-8","article-title":"Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia","volume":"104","author":"Zhang","year":"2025","journal-title":"Ann Hematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19759","article-title":"Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications","volume":"205","author":"Cicconi","year":"2024","journal-title":"Br J Haematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05776-y","article-title":"Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide","volume":"103","author":"Gao","year":"2024","journal-title":"Ann Hematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41419-025-08109-7","article-title":"Anti-inflammatory 25(Oh)D(3), a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia","volume":"16","author":"Jambrovics","year":"2025","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2462","article-title":"Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study by the Pethema Group","volume":"103","author":"Sanz","year":"2004","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European Leukemianet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168617","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors","volume":"113","author":"Montesinos","year":"2009","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41408-024-01074-y","article-title":"Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia","volume":"14","author":"Wu","year":"2024","journal-title":"Blood Cancer J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-025-01556-1","article-title":"Understanding the differentiation syndrome in acute promyelocytic leukemia: A comprehensive updated review","volume":"43","author":"Damaj","year":"2025","journal-title":"Invest New Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00277-026-06729-3","article-title":"Does differentiation syndrome in newly diagnosed acute promyelocytic leukemia warrant systemic antifungal therapy? A real-world clinical study","volume":"105","author":"Jiang","year":"2026","journal-title":"Ann Hematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041775","article-title":"Differentiation syndrome in acute myeloid leukemia: Molecular mechanisms, clinical spectrum, and emerging therapeutic paradigms","volume":"27","author":"Mansour","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101370","article-title":"The expression of Slit2 and Robo1 increased during retinoic acid syndrome in acute promyelocytic leukemia and impacted differentiated cell migration","volume":"18","author":"Yang","year":"2022","journal-title":"Transl Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06251-y","article-title":"Thromboembolism in adult patients with acute promyelocytic leukemia: Clinical characteristics, risk factors, and a predictive nomogram","volume":"104","author":"Hao","year":"2025","journal-title":"Ann Hematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04245-6","article-title":"Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia","volume":"99","author":"Minamiguchi","year":"2020","journal-title":"Ann Hematol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1742083","article-title":"Influence of white blood cell count trajectories on the risk of differentiation syndrome during induction therapy with all-trans-retinoic acid and arsenic trioxide in pediatric acute promyelocytic leukemia","volume":"13","author":"Fu","year":"2025","journal-title":"Front Pediatr"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1961271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:20:16Z","timestamp":1789734016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1961271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":33,"alternative-id":["10.3389\/fonc.2026.1961271"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1961271","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1961271"}}